January 3, 2020
Stockholm-based respiratory health startup NuvoAir is set to make its technology available in selected cystic fibrosis (CF) centres after entering a new partnership with Roche Italy.
This marks NuvoAir’s first CF deal with a pharma company.
WHY IT MATTERS
According to the UK-based Cystic Fibrosis Trust, the genetic condition is estimated to affect around 100,000 people globally. It causes a...
April 18, 2017
There’s been a lot of talk about sweat-centric technology, with hopeful researchers and digital health entrepreneurs citing the potential for wearables that measure the salty substance to offer up a bevy of biometric insights ranging from athletic performance to glucose monitoring. But the latest scientific undertaking suggests sweat-sensing wearables could go much further: diagnosing disease.
April 17, 2014
The Inspiromatic inhaler.
Biopharmaceutical company Opko Health has acquired Israeli smart inhaler company Inspiro Medical for a sum in "the low eight figures", according to Opko's Director of Strategic Investment Les Funtleyder. The company will be using Inspiro's Inspiromatic technology to develop an app-connected inhaler that will be bundled with a forthcoming new drug for asthma, COPD, and...
April 4, 2013
Madison, Wisconsin-based Asthmapolis, which offers a FDA-cleared inhaler sensor and app for people with asthma, COPD, or cystic fibrosis, announced that it has raised $5 million in its first round of funding. The investment was led by The Social+Capital Partnership, a relatively new venture fund started by Chamath Palihapitiya, an early executive at Facebook who left to start the investment fund...